Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
04/22/2004 | US20040077056 By culturing a Shingomonas bacteria in a fermentation broth for a time and temperature effective for providing a sphingan exopolysaccharide in a slime form |
04/22/2004 | US20040077051 LSR receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications |
04/22/2004 | US20040077047 Allows efficient production of heterologous protein and wherein any contamination of the product protein by vegetative spores is avoided |
04/22/2004 | US20040077046 Histone deacetylase-related gene and protein |
04/22/2004 | US20040077045 Melanoma Associated antigen (MAGE) tumor associated genes, nucleic acids encoding such peptides and antibodies relating thereto; Human Leukocyte Antigen (HLA) |
04/22/2004 | US20040077038 Methods for production of proteins in host cells |
04/22/2004 | US20040077035 Mutated penicillin expandase and process for preparing 7-ADCA using the same |
04/22/2004 | US20040077034 Mutated penicillin expandase and process for preparing 7-ADCA using the same |
04/22/2004 | US20040077029 Human protooncogene and protein encoded therein |
04/22/2004 | US20040077016 The bacteria are good research materials for investigating the interrelation between enzyme structures and functions since they are stable at extreme pH, crystallize easily and are easy- to-handle |
04/22/2004 | US20040077012 Thermostable DNA polymerases that can serve as chromosomal replicases and are derived from thermophilic bacteria |
04/22/2004 | US20040077009 Human cyclin-dependent kinase (hPNQALRE) |
04/22/2004 | US20040077007 Human SMN-like protein |
04/22/2004 | US20040077002 Useful in the study of vascular smooth muscle cell proliferation and in the treatment of blood vessel diseases that result from excessive smooth muscle cell proliferation, particularly after balloon angioplasty; atherosclerosis |
04/22/2004 | US20040077000 Using cynomologous monkey P-glycoprotein nucleic acids and polypeptides in determining bioavailability of drugs and for screening for inhibitors of cynomologous P-glycoprotein |
04/22/2004 | US20040076992 Novel cell adhesion molecule specific to activated leukocyte |
04/22/2004 | US20040076990 Universal method and composition for the rapid lysis of cells for the release of nucleic acids and their detection |
04/22/2004 | US20040076986 A gene and/or a protein involved in the prevention or treatment of allergic diseases and dermatitis |
04/22/2004 | US20040076985 Reagents which regulate human chemokine-like receptor and reagents which bind to human chemokine-like receptor gene products, useful in preventing, ameliorating, or correcting dysfunctions or diseases including HIV infection, |
04/22/2004 | US20040076982 3-hydroxypropionic acid and other organic compounds |
04/22/2004 | US20040076955 Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer |
04/22/2004 | US20040076951 Also antibodies, gene chips, transgenic non-human animals |
04/22/2004 | US20040076638 Methods for preparing bacillus anthracis protective antigen for use in vaccines |
04/22/2004 | US20040076625 A fusion proteins comprising self or non-self antigens, is used for treatment and prevention of immunoglobulin E related diseases, gene expression |
04/22/2004 | US20040076615 Genetic engineered primers with nucleotide sequences, for treating diarrhea, colitis, intestinal infections, candida infections or skin diseases |
04/22/2004 | US20040076614 For natural cellular immune defense in humans/animals; for foods/feeds |
04/22/2004 | US20040076607 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
04/22/2004 | DE10247755A1 New fusion polypeptide, useful for treating e.g. cancer, infections and inflammation, comprises binding domain for cell-surface molecule and fragment of tumor necrosis factor ligand |
04/22/2004 | CA2501875A1 Cap-binding protein |
04/22/2004 | CA2501851A1 Circular dna molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
04/22/2004 | CA2501752A1 Compositions, organisms and methodologies employing a novel human kinase |
04/22/2004 | CA2501574A1 Process for the biological production of 1,3-propanediol with high yield |
04/22/2004 | CA2501445A1 Polypeptides involved in spiramycin biosynthesis, nucleotide sequences encoding said polypeptides and uses thereof |
04/22/2004 | CA2500741A1 Glucose transport mutants for production of biomaterial |
04/22/2004 | CA2500592A1 Compositions, organisms and methodologies employing a novel human kinase |
04/22/2004 | CA2499609A1 Culture method of controlling the composition of copolymer polyester |
04/22/2004 | CA2499607A1 Method of coagulating poly-3-hydroxyalkanoic acid |
04/21/2004 | EP1411126A1 Nitrilase and encoding polynucleotide |
04/21/2004 | EP1411121A1 Dna fragments containing gene having function relating to autonomous proliferation of plasmid |
04/21/2004 | EP1411116A1 PEPTIDE SYNTHASE GENE, PEPTIDE SYNTHASE AND PROCESS FOR PRODUCING DIPEPTIDE |
04/21/2004 | EP1411064A2 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours |
04/21/2004 | EP1411062A1 Process for producing dipeptide,peptide synthase to be used therein and process for producing peptide synthase |
04/21/2004 | EP1411060A1 PROCESS FOR PRODUCING DIPEPTIDE, L−AMINO ACID AMIDE HYDROLASE TO BE USED THEREIN AND PROCESS FOR PRODUCING L−AMINO ACID AMIDE HYDROLASE |
04/21/2004 | EP1410038A2 Assays for identifying modulators of rhomboid polypeptides |
04/21/2004 | EP1409748A2 Method for rapid screening of bacterial transformants and novel simian adenovirus proteins |
04/21/2004 | EP1409738A1 Methods and oligonucleotides for the detection of salmonella sp.,e.coli o157:h7,and listeria monocytogenes |
04/21/2004 | EP1409715A2 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
04/21/2004 | EP1409708A2 Glucans and glucansucrases derived from lactic acid bacteria |
04/21/2004 | EP1409703A2 Metabolic controlled fermentation process for pseudomonic acid production |
04/21/2004 | EP1409694A1 Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof |
04/21/2004 | EP1409691A2 Stereoselective preparation of cyclic l-amino acids |
04/21/2004 | EP1409688A2 Nucleic acid sequences encoding enantioselective amidases |
04/21/2004 | EP1409684A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
04/21/2004 | EP1409683A2 i HELICOBACTER /i PROTEINS, NUCLEIC ACIDS AND USES THEREOF |
04/21/2004 | EP1409681A2 Proteins and nucleic acids encoding same |
04/21/2004 | EP1409680A2 Novel human proton-gated channels |
04/21/2004 | EP1409677A2 Receptors and membrane-associated proteins |
04/21/2004 | EP1409673A2 Human leucine-rich repeat containing protein, expressed predominantely in small intestine, hlrrsi1 |
04/21/2004 | EP1409665A2 Method to generate non virulent microorganisms from pathogenic ones trough permanent genetic modification of their biological membrane for vaccine production |
04/21/2004 | EP1409661A2 Hdac9 polypeptides and polynucleotides and uses thereof |
04/21/2004 | EP1409660A2 Crystal structure of beta-site app cleaving enzyme (bace) and use thereof |
04/21/2004 | EP1409659A2 Subtilase variants |
04/21/2004 | EP1409658A2 Aggrecanase molecules |
04/21/2004 | EP1409655A2 Immunoglobulin superfamily proteins |
04/21/2004 | EP1409645A1 Probiotic lactobacillus salivarius strains |
04/21/2004 | EP1409644A1 Probiotic bifidobacterium strains |
04/21/2004 | EP1409643A1 Probiotic lactobacillus casei strains |
04/21/2004 | EP1409642A1 Thermophilic microorganism bacillus coagulans strain sim-t dsm 14043 for the production of l(+)-lactate from fermentable sugars and their mixtures |
04/21/2004 | EP1409641A2 Engineering fungi for the utilisation of l-arabinose |
04/21/2004 | EP1409640A1 Adaptation of bacteria for use in leaching |
04/21/2004 | EP1409550A1 Extracellular messengers |
04/21/2004 | EP1409547A2 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer |
04/21/2004 | EP1409545A2 Allelic variants of grp50 |
04/21/2004 | EP1409542A2 Blood group antigen fusion polypeptides and methods of use thereof |
04/21/2004 | EP1409535A2 Human secreted proteins |
04/21/2004 | EP1409533A2 Recombinant plasmodium falciparum merozoite protein-1/42 vaccine |
04/21/2004 | EP1409528A2 Novel compounds |
04/21/2004 | EP1409523A2 Pancam nucleic acids and polypeptides |
04/21/2004 | EP1409517A2 Fusion proteins based upon somatostatin receptors |
04/21/2004 | EP1409010A1 Treating endotoxemia and related disorders with probiotics |
04/21/2004 | EP1408909A2 Improved conditionally replicating vectors for inhibiting viral infections |
04/21/2004 | EP1408811A2 Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer |
04/21/2004 | EP1408808A2 Methods for diagnosing and treating heart disease |
04/21/2004 | EP1408760A2 Consumable product containing probiotics |
04/21/2004 | EP1191707B1 Power amplifier sharing in a wireless communication system with transmit diversity |
04/21/2004 | EP1018341B1 Antistress agents and functional foods |
04/21/2004 | EP0836647B1 Antiviral proteins, dna coding sequences therefor, and uses thereof |
04/21/2004 | CN1491282A Process for producing prenyl alcohol |
04/21/2004 | CN1491281A Neurotonin and use thereof |
04/21/2004 | CN1491280A Synovial membrane cell protein |
04/21/2004 | CN1491278A Lipase variants |
04/21/2004 | CN1491116A Hepatitis B virus treatment |
04/21/2004 | CN1490406A Recombined human organ plasminogen activator streptokinase and its preparation |
04/21/2004 | CN1490398A Bacillus pumilus for killing nematoda and its preparation and use |
04/21/2004 | CN1490397A Preservation of living bacteria in biological products by corn starch |
04/21/2004 | CN1490396A Zytase, its producing method and special bacterial strain for production |
04/21/2004 | CN1490280A Microorganic fertilizer against various bacteria and its preparation and use |
04/21/2004 | CN1490049A CD26/DPP IV application for medicine in preparing treatment and/or diagnostic disease |
04/21/2004 | CN1146664C Fusion polypeptides comprising and IgE-binding domain and HSA component, and their diagnostic and therapeutic uses |
04/21/2004 | CN1146663C Selection marker |